Jason Hsu, Director at Immix Biopharma, Inc. (IMMX), bought 56,000 shares at $4.67 ($267K) on 2023-12-11, disclosed to the SEC on 2023-12-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.88 | 25,000 | $122K | 45.7% |
| 2 | $4.67 | 31,000 | $145K | 54.3% |
| Total | $4.76 avg | 56,000 | $267K | 100% |
| Filing → |
| IMMX | BUY | 2024-07-31 | $20K | — | Filing → |
| IMMX | BUY | 2023-09-18 | $200K | — | Filing → |
| IMMX | BUY | 2023-09-12 | $25K | — | Filing → |